Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients.
Wang, Emily
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Oct 2019 - 1731-1737 p. digital
Publication Type: Journal Article
1477-092X
10.1177/1078155218796188 doi
Adult
Aged
Cytomegalovirus Infections--drug therapy
DNA, Viral
DNA-Directed DNA Polymerase--genetics
Female
Genotype
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Leflunomide--administration & dosage
Male
Middle Aged
Mutation
Retrospective Studies
Viral Proteins--genetics
Young Adult
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Oct 2019 - 1731-1737 p. digital
Publication Type: Journal Article
1477-092X
10.1177/1078155218796188 doi
Adult
Aged
Cytomegalovirus Infections--drug therapy
DNA, Viral
DNA-Directed DNA Polymerase--genetics
Female
Genotype
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Leflunomide--administration & dosage
Male
Middle Aged
Mutation
Retrospective Studies
Viral Proteins--genetics
Young Adult